These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prostate cancer presenting with normal serum PSA levels and boney metastases treated with zoledronic acid. Mystakidou K; Katsouda E; Parpa E; Vlahos L J Pain Palliat Care Pharmacother; 2005; 19(3):41-5. PubMed ID: 16219610 [TBL] [Abstract][Full Text] [Related]
4. Heel pain as the inaugural manifestation of metastatic prostate cancer. Gisserot O; Jaureguiberry JP; Carli P; Paris JF; Jaubert D; Chagnon A Rev Rhum Engl Ed; 1996 Dec; 63(11):870-1. PubMed ID: 9010979 [No Abstract] [Full Text] [Related]
5. Correlation of strontium-85 photoscanning with skeletal x-ray surveys in patients with carcinoma of the prostate. Johnson DE; Haynie TP J Surg Oncol; 1972; 4(2):102-8. PubMed ID: 5033029 [No Abstract] [Full Text] [Related]
6. Treatment of metastatic prostate adenocarcinoma to the calcaneus. Bibbo C; Hatfield SP; Albright JT J Foot Ankle Surg; 2010; 49(2):159.e15-20. PubMed ID: 20015665 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic challenges of clonal heterogeneity in prostate cancer. Haffner MC; De Marzo AM; Yegnasubramanian S; Epstein JI; Carter HB J Clin Oncol; 2015 Mar; 33(7):e38-40. PubMed ID: 24638011 [No Abstract] [Full Text] [Related]
8. Metastatic prostate cancer: complications and treatment. McMurtry CT; McMurtry JM J Am Geriatr Soc; 2003 Aug; 51(8):1136-42. PubMed ID: 12890079 [TBL] [Abstract][Full Text] [Related]
9. Radioisotope bone scanning characteristics of metastatic skeletal deposits of prostatic adenocarcinoma. Kane RD; Paulson DF J Urol; 1977 May; 117(5):618-21. PubMed ID: 859203 [TBL] [Abstract][Full Text] [Related]
10. Penile metastasis from prostate cancer: a case report. Cante D; Franco P; Sciacero P; Girelli G; Casanova Borca V; Grosso P; Tofani S; Marra A; La Porta MR; Ricardi U Tumori; 2014; 100(1):e14-6. PubMed ID: 24675501 [TBL] [Abstract][Full Text] [Related]
12. [The role of PSA in prostatic adenocarcinoma]. Manca GP Minerva Med; 1990 Apr; 81(4):261-4. PubMed ID: 1692981 [TBL] [Abstract][Full Text] [Related]
13. HOXB13 as an immunohistochemical marker of prostatic origin in metastatic tumors. Barresi V; Ieni A; Cardia R; Licata L; Vitarelli E; Reggiani Bonetti L; Tuccari G APMIS; 2016 Mar; 124(3):188-93. PubMed ID: 26590121 [TBL] [Abstract][Full Text] [Related]
14. Osteoblastic response to successful treatment of metastatic cancer of the prostate. Pollen JJ; Shlaer WJ AJR Am J Roentgenol; 1979 Jun; 132(6):927-31. PubMed ID: 108971 [TBL] [Abstract][Full Text] [Related]
15. Clinical and pathologic features of initial metastatic presentations of renal cell carcinoma. Silverberg SG; Evans RH; Koehler AL Cancer; 1969 May; 23(5):1126-32. PubMed ID: 5778234 [No Abstract] [Full Text] [Related]
16. External beam radiotherapy for palliation of pain from metastatic carcinoma of the prostate. Benson RC; Hasan SM; Jones AG; Schlise S J Urol; 1982 Jan; 127(1):69-71. PubMed ID: 6173495 [TBL] [Abstract][Full Text] [Related]
18. Skeletal survey for metastatic tumors of bone usine 18F and 85Sr with scintillation camera and whole-body scanner. Ronai P; Winchell HS; Anger HO J Nucl Med; 1968 Oct; 9(10):517-22. PubMed ID: 5729200 [No Abstract] [Full Text] [Related]
19. Technetium polyphosphate bone scans in carcinoma of prostate. Redman JF; Turley JT Urology; 1973 Mar; 1(3):218-20. PubMed ID: 4802058 [No Abstract] [Full Text] [Related]
20. Bone marrow examination as a diagnostic tool in carcinoma of the prostate. Duchek M; Lingardh G; Saterborg NE; Winblad B; Angström T Int Urol Nephrol; 1975; 7(1):59-64. PubMed ID: 1150393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]